FDA Inspection 829763 — Michigan Reproductive Medicine
The FDA completed an inspection of Michigan Reproductive Medicine on Apr 1, 2013 in Bloomfield Hills, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 1, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bloomfield Hills, MI (United States)